Clinical Trial Update: Immune Response Activation for the Treatment of Unresectable Metastatic Colorectal Cancer or CEA Positive Metastatic Breast Cancer [Phase 1]

View source ↗

Summary

Phase 1 study evaluating an immune response activation approach for unresectable metastatic colorectal cancer or CEA-positive metastatic breast cancer. The tria…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Cancer

Snippet

Sponsor: City of Hope Medical Center | Conditions: Breast Carcinoma, Colorectal Carcinoma | Phase 1 | Status: RECRUITING